ClariTrial | Search Clinical Trials

Explore/cardiovascular heart disease

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

586 results for “cardiovascular heart disease” · Recruiting · Phase 3 · Phase 2

Page 1 of 40

Recruiting

Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled Pilot Trial

Phase 2Cavernous MalformationsIntracerebral HemorrhageBrainstem Stroke

SirolimusStarch flake

Huashan Hospital75 participants2 sites · ChinaCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Phase 3Childhood Extracranial Germ Cell TumorExtragonadal Embryonal CarcinomaGerm Cell Tumor

Best PracticeBiopsy ProcedureBiospecimen Collection+8 more

Children's Oncology Group1,780 participants629 sites · United States, Australia, CanadaCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation

Phase 2Right Heart FailureRight Ventricular Dysfunction

Combined Epoprostenol Sodium & MilrinoneNormal saline

Montreal Heart Institute141 participants1 site · CanadaCompletes May 2028

Compare CT.gov Full analysis →

Recruiting

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

Phase 2Atrial FibrillationEsophageal Carcinoma

Amiodarone HydrochlorideSaline

OHSU Knight Cancer Institute90 participants1 site · United StatesCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients

Phase 3Heart FailureChronic Kidney Diseases

Sodium Zirconium CyclosilicateStandard of care treatment (RAASi therapy)

Fundación para la Investigación del Hospital Clínico de Valencia94 participants6 sites · SpainCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

POHCA Resuscitation: Evaluation of IM Epinephrine

Phase 2Phase 3Pediatric Out-of-Hospital Cardiac Arrest

Epinephrine Injection

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's284 participants1 site · CanadaCompletes Jan 2028

Compare CT.gov Full analysis →

Recruiting

Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome

Phase 3Vascular Ehlers-Danlos Syndrome

ACER-002 (celiprolol) 200 mg BIDPlacebo BID

Acer Therapeutics Inc.150 participants1 site · United StatesCompletes Mar 2029

Compare CT.gov Full analysis →

Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Phase 3Heart FailureHeart Failure With Reduced Ejection Fraction

Omecamtiv Mecarbil (OM)Placebo

Cytokinetics1,800 participants209 sites · United States, Canada, ChinaCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest

Phase 2Out-of-hospital Cardiac Arrest (OHCA)

esketamine hydrochloridepropofol

Christian Hassager282 participants2 sites · DenmarkCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

Phase 2Pulmonary Arterial Hypertension (PAH)

REGN13335Placebo

Regeneron Pharmaceuticals99 participants32 sites · United States, Australia, BelgiumCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

A Polypill for Acute Coronary Syndrome

Phase 2Acute Coronary Syndrome

Polypill

University of Texas Southwestern Medical Center1,000 participants4 sites · United StatesCompletes Jun 2030

Compare CT.gov Full analysis →

Recruiting

Selenium Intervention Registry Randomized Trial in Heart Failure

Phase 3Heart FailureHeart Failure and Reduced Ejection FractionHeart Failure and Mildly Reduced Ejection Fraction

Selenium SupplementPlacebo

Skane University Hospital4,326 participants11 sites · Norway, SwedenCompletes Mar 2030

Compare CT.gov Full analysis →

Recruiting

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Phase 2Phase 3MenopauseMenopause Hot FlashesMenopause Related Conditions

MetforminsemaglutideAnti-hypertensives+4 more

University of Colorado, Denver200 participants3 sites · United StatesCompletes Oct 2029

Compare CT.gov Full analysis →

Recruiting

Use of Phenylephrine for Assessment of Mitral Regurgitation Severity

Phase 1Phase 2Mitral Regurgitation

Mydfrin

Montefiore Medical Center35 participants1 site · United StatesCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease

Phase 2Stroke (CVA) or TIACarotid Artery PlaqueAtherosclerosis Cardiovascular Disease

[18F]AlF-OC

Universitaire Ziekenhuizen KU Leuven24 participants1 site · BelgiumCompletes Sep 2026

Compare CT.gov Full analysis →

1–15 of 586

Explore/cardiovascular heart disease

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

586 results for “cardiovascular heart disease” · Recruiting · Phase 3 · Phase 2

Page 1 of 40

Recruiting

Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: aSingle Centre, Randomized, Placebo-controlled Pilot Trial

Phase 2Cavernous MalformationsIntracerebral HemorrhageBrainstem Stroke

SirolimusStarch flake

Huashan Hospital75 participants2 sites · ChinaCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Phase 3Childhood Extracranial Germ Cell TumorExtragonadal Embryonal CarcinomaGerm Cell Tumor

Best PracticeBiopsy ProcedureBiospecimen Collection+8 more

Children's Oncology Group1,780 participants629 sites · United States, Australia, CanadaCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation

Phase 2Right Heart FailureRight Ventricular Dysfunction

Combined Epoprostenol Sodium & MilrinoneNormal saline

Montreal Heart Institute141 participants1 site · CanadaCompletes May 2028

Compare CT.gov Full analysis →

Recruiting

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

Phase 2Atrial FibrillationEsophageal Carcinoma

Amiodarone HydrochlorideSaline

OHSU Knight Cancer Institute90 participants1 site · United StatesCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients

Phase 3Heart FailureChronic Kidney Diseases

Sodium Zirconium CyclosilicateStandard of care treatment (RAASi therapy)

Fundación para la Investigación del Hospital Clínico de Valencia94 participants6 sites · SpainCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

POHCA Resuscitation: Evaluation of IM Epinephrine

Phase 2Phase 3Pediatric Out-of-Hospital Cardiac Arrest

Epinephrine Injection

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's284 participants1 site · CanadaCompletes Jan 2028

Compare CT.gov Full analysis →

Recruiting

Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome

Phase 3Vascular Ehlers-Danlos Syndrome

ACER-002 (celiprolol) 200 mg BIDPlacebo BID

Acer Therapeutics Inc.150 participants1 site · United StatesCompletes Mar 2029

Compare CT.gov Full analysis →

Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Phase 3Heart FailureHeart Failure With Reduced Ejection Fraction

Omecamtiv Mecarbil (OM)Placebo

Cytokinetics1,800 participants209 sites · United States, Canada, ChinaCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest

Phase 2Out-of-hospital Cardiac Arrest (OHCA)

esketamine hydrochloridepropofol

Christian Hassager282 participants2 sites · DenmarkCompletes Sep 2027

Compare CT.gov Full analysis →

Recruiting

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

Phase 2Pulmonary Arterial Hypertension (PAH)

REGN13335Placebo

Regeneron Pharmaceuticals99 participants32 sites · United States, Australia, BelgiumCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

A Polypill for Acute Coronary Syndrome

Phase 2Acute Coronary Syndrome

Polypill

University of Texas Southwestern Medical Center1,000 participants4 sites · United StatesCompletes Jun 2030

Compare CT.gov Full analysis →

Recruiting

Selenium Intervention Registry Randomized Trial in Heart Failure

Phase 3Heart FailureHeart Failure and Reduced Ejection FractionHeart Failure and Mildly Reduced Ejection Fraction

Selenium SupplementPlacebo

Skane University Hospital4,326 participants11 sites · Norway, SwedenCompletes Mar 2030

Compare CT.gov Full analysis →

Recruiting

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Phase 2Phase 3MenopauseMenopause Hot FlashesMenopause Related Conditions

MetforminsemaglutideAnti-hypertensives+4 more

University of Colorado, Denver200 participants3 sites · United StatesCompletes Oct 2029

Compare CT.gov Full analysis →

Recruiting

Use of Phenylephrine for Assessment of Mitral Regurgitation Severity

Phase 1Phase 2Mitral Regurgitation

Mydfrin

Montefiore Medical Center35 participants1 site · United StatesCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease

Phase 2Stroke (CVA) or TIACarotid Artery PlaqueAtherosclerosis Cardiovascular Disease

[18F]AlF-OC

Universitaire Ziekenhuizen KU Leuven24 participants1 site · BelgiumCompletes Sep 2026

Compare CT.gov Full analysis →

1–15 of 586